The Association of Community Cancer Centers (ACCC), Hematology/Oncology Pharmacy Association (HOPA), National
Community Oncology Dispensing Association, Inc. (NCODA), and Oncology Nursing Society (ONS) have collaborated in gathering
information for and developing this patient education guide. This guide represents a brief summary of the medication derived from
information provided by the drug manufacturer and other resources. This guide does not cover all existing information related to the
possible uses, directions, doses, precautions, warnings, interactions, adverse effects, or risks associated with this medication and should
not substitute for the advice of a qualified healthcare professional. Provision of this guide is for informational purposes only and does
not constitute or imply endorsement, recommendation, or favoring of this medication by ACCC, HOPA, NCODA, or ONS, who assume
no liability for and cannot ensure the accuracy of the information presented. The collaborators are not making any representations with
respect to the medications whatsoever, and any and all decisions, with respect to such medications, are at the sole risk of the individual
consuming the medication. All decisions related to taking this medication should be made with the guidance and under the direction of a
qualified healthcare professional.
Permission:
Oral Chemotherapy Education (OCE) sheets are provided as a free educational resource for patients with cancer in need of
concise, easy-to-understand information about oral cancer drugs. Healthcare providers are permitted to copy and distribute the sheets to
patients as well as direct patients to the OCE website for information. However, commercial reproduction or reuse, as well as rebranding
or reposting of any type, are strictly prohibited without permission of the copyright holder. Please email permission requests and licensing
inquiries to Contact@NCODA.org.
Cookies are required to agree to our terms of service. We only use this cookie to grant access to our library.
Zydelig® (Idelalisib) is used to treat adults with certain types of leukemias and lymphomas, specifically the following:
• Chronic lymphocytic leukemia (CLL)
•Follicular B-cell non-Hodgkin lymphoma (FL)
•Small lymphocytic lymphoma (SLL)
Zydelig® (Idelalisib) is used to treat adults with certain types of leukemias and lymphomas, specifically the following:
• Chronic lymphocytic leukemia (CLL)
•Follicular B-cell n...
Zykadia® (Ceritinib) is used to treat metastatic non-small cell lung cancer (NSCLC) that has a genetic mutation of the anaplastic lymphoma kinase (ALK) gene.
Zykadia® (Ceritinib) is used to treat metastatic non-small cell lung cancer (NSCLC) that has a genetic mutation of the anaplastic lymphoma kinase (ALK) gene.
Zytiga® (Abiraterone Acetate) is used for treatment of metastatic castration-resistant prostate cancer (CRPC) and treatment of metastatic high-risk castration-sensitive prostate cancer (CSPC). Yonsa is used for treatment of metastatic castration-resistant prostate cancer (CRPC).
Zytiga® (Abiraterone Acetate) is used for treatment of metastatic castration-resistant prostate cancer (CRPC) and treatment of metastatic high-risk castration-sensitive prostate cancer (CSPC). Yonsa is used for treatm...